Home Pilots Seer Medical receives FDA 510(k) for its at-home epilepsy diagnosis aide Pilots Seer Medical receives FDA 510(k) for its at-home epilepsy diagnosis aide By - September 26, 2022 41 0 Facebook Twitter Pinterest WhatsApp The company’s Seer Home device allows for potential epilepsy diagnosis through at-home data collection. RELATED ARTICLESMORE FROM AUTHOR Pilots Medtronic issues voluntary recall of MiniMed insulin pumps Pilots Hybrid primary care company Rezilient Health scores $10M Pilots Empathy Health Technologies raises $2.8M for Sober Sidekick app LEAVE A REPLY Cancel reply Please enter your comment! Please enter your name here You have entered an incorrect email address! Please enter your email address here Save my name, email, and website in this browser for the next time I comment. FOLLOW ME0FansLike0FollowersFollow0SubscribersSubscribe POPULAR ARTICLES NTU researchers develop marker-less motion capture tech for physiotherapy Pilots - April 4, 2022 0 Exclusive Q&A: How digital health solutions can make money Pilots - July 7, 2023 0 Wearable company Oura acquires digital identification startup Proxy Pilots - May 10, 2023 0 Headspace launches direct-to-consumer mental health coaching Pilots - April 23, 2024 0 Medication risk analysis company MDI Health raises $20M Pilots - February 16, 2023 0 POPULAR CATEGORIESPilots2166Applications750Testing283Collaborations15GitHub3